Research

What happens between visits, and what can we learn from it?

Claims, EHRs, registries, and longitudinal datasets can show diagnoses, medications, utilization, procedures, and documented risk factors.

They usually cannot show every rhythm event that happens between scheduled encounters, or what a person's rhythm looked like in the days between them.

MbeleMed's research strategy connects those two layers.

Discuss a Research Collaboration
A pregnant woman smiles while talking with a physician at home

The research loop

  1. 01

    Learn from longitudinal populations

    Study appropriately governed clinical and utilization data to understand which signals are associated with higher risk.

  2. 02

    Define the right people to study

    Pre-specify populations whose observed risk may justify additional study or monitoring.

  3. 03

    Add continuous rhythm data

    Use appropriate monitoring services within an approved study or pilot.

  4. 04

    Have findings reviewed

    Qualified physicians confirm findings according to the study or program protocol.

  5. 05

    Measure what happened

    Evaluate monitoring yield, phenotype, follow-up, utilization, and other pre-specified endpoints.

  6. 06

    Ask a better question

    Use what the program teaches us to improve future cohort selection and monitoring strategies.

Senior cardiovascular research

Start with the people most likely to benefit.

MbeleMed is developing research on whether longitudinal clinical information can improve targeting of extended rhythm monitoring in older adults at elevated risk of previously undetected, clinically actionable arrhythmias.

Questions include:

  • which clinical and utilization signals enrich monitoring yield;
  • how broader rhythm detection compares with AF-only screening;
  • which monitoring durations fit specific risk populations;
  • how physician-confirmed findings connect to downstream action;
  • how methods transport across datasets and populations.

Maternal & postpartum cardiovascular research

The postpartum period deserves better visibility between visits.

MbeleMed is developing a research-stage maternal and postpartum program around two questions:

  1. Can longitudinal clinical information identify women at elevated short-term risk of cardiac rhythm complications during pregnancy and the first year postpartum?
  2. What does targeted continuous rhythm monitoring reveal between scheduled visits?

Hypertensive disorders of pregnancy and peripartum cardiomyopathy may provide important clinical context, risk factors, or outcomes. They are not being presented as direct ECG endpoints.

Potential rhythm endpoints include:

  • atrial arrhythmias;
  • supraventricular tachyarrhythmias;
  • ventricular arrhythmias;
  • bradycardia and pauses;
  • conduction abnormalities;
  • clinically meaningful ectopy;
  • QT-related abnormalities where the monitoring modality and protocol support appropriate measurement.

This remains research-stage work, not a validated maternal diagnostic product.

Current activity

MbeleMed is preparing multiple study submissions across senior and maternal cardiovascular research programs.

MbeleMed is also preparing for early pilot pathways. No statement on this page should be read as implying protocol approval, enrollment, publication, or clinical validation unless separately stated.

Research governance

Research and care are related. They are not the same thing.

Patient-level research use requires the applicable protocol, review, consent or authorization where required, data-use permissions, access controls, and publication/output rights.

Commercial participation does not automatically create research rights.

Confidence comes from knowing where the evidence stands.

  1. PublishedExternal evidenceWhat others have shown.
  2. CapabilityImplemented workflowWhat the platform can do.
  3. PilotDefined programWhat a real program is testing.
  4. ResearchStudy-stage methodsWhat we are still learning.

Better questions lead to better monitoring.

Discuss a Research Collaboration Review Evidence & Safety